Long-term outcomes and patterns of failure after empiric SBRT for presumed early-stage lung tumors
Empiric SBRT provides durable local control in presumed early-stage NSCLC, but outcomes are limited by comorbid mortality and systemic progression. These findings emphasize its effectiveness as a local therapy and the need for prolonged surveillance and systemic strategies.
Authors
- Lukas Käsmann (ORCID: https://orcid.org/0000-0001-6260-5249)
- Sophie Kröninger
- Chukwuka Eze (ORCID: https://orcid.org/0000-0003-3779-1398)
- Claus Belka (ORCID: https://orcid.org/0000-0002-1287-7825)
- Amanda Tufman (ORCID: https://orcid.org/0000-0001-9243-9050)
- Sina Mansoorian
- Thomas Duell (ORCID: https://orcid.org/0000-0002-1039-2090)
- Esra Degerli
- Niels Reinmuth (ORCID: https://orcid.org/0000-0002-7369-4512)
- Farkhad Manapov
- Diego Kauffmann‐Guerrero (ORCID: https://orcid.org/0000-0003-1471-3290)
- Karim El-Marouk
Institutions
- German Cancer Research Center (DE)
- Heidelberg University (DE)
- Asklepios Fachkliniken München-Gauting (DE)
- German Center for Lung Research (DE)
- Ludwig-Maximilians-Universität München (DE)
- Fresenius Medical Care (Germany) (DE)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-11-25
- DOI
- https://doi.org/10.3389/fonc.2025.1705311
- Primary Topic
- Lung Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00